Next Article in Journal
Resilience and Self-Esteem Mediated Associations between Childhood Emotional Maltreatment and Aggression in Chinese College Students
Next Article in Special Issue
Food and Development: Children and Adolescents with Neurodevelopmental and Comorbid Eating Disorders—A Case Series
Previous Article in Journal
Pre-Molecular Assessment of Self-Processes in Neurotypical Subjects Using a Single Cognitive Behavioral Intervention Evoking Autobiographical Memory
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Diagnostic and Therapeutic Challenges of Comorbid ASD, ADHD and Psychosis: A Case Report

Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy
*
Authors to whom correspondence should be addressed.
Behav. Sci. 2022, 12(10), 382; https://doi.org/10.3390/bs12100382
Submission received: 18 August 2022 / Revised: 19 September 2022 / Accepted: 29 September 2022 / Published: 6 October 2022

Abstract

:
Autism Spectrum Disorder (ASD) and attention deficit hyperactivity disorder (ADHD) comorbidity is common in clinical practice and it seems to be related to shared etiological mechanisms and genetic susceptibility. Moreover, occurrence of psychosis can further complicate these complex clinical pictures. Here, we discuss the case of a nine-years-old boy presenting with an episode of abnormal sustained posture of the upper limbs, resembling dystonia, at the age of 3. At this time, auditory and visual hallucinations, as well as obsessive thoughts and attentional lability were also present and a diagnosis of “Early onset psychosis” was initially made. Due to the worsening of clinical picture, several hospitalizations were necessary and pharmacological treatment with carbamazepine, risperidone and aripiprazole was carried out. Extensive clinic evaluation revealed a past medical and personal history of toe walking, weak social skills and stereotyped behavior observed and ADOS-2 Module 2 administration revealed severe Autism scores. Moreover, signs of attention and hyperactivity were consistent with ADHD diagnosis. This work highlights the importance of a complete diagnostic assessment in patients with complex presentation, suggesting the possible overlap diagnosis of ADHD and Autism even in presence of psychotic-like symptoms.

1. Introduction

A high rate of multiple comorbidities in neurodevelopmental disorders is a common finding [1]. Between 37–85% of Autism Spectrum Disorder (ASD) are estimated to present comorbid attention deficit hyperactivity disorder (ADHD) symptoms, with amplification of negative impact on quality of life [2,3]. Moreover, psychotic disorders may further complicate these clinical pictures, resulting in diagnostic and therapeutic challenges for pediatric psychiatrists. We should consider that ASD and schizophrenia are both characterized by atypical neuro-development of language and difficulties with social interaction and communication and ASD symptoms appear to overlap most significantly with negative symptoms of schizophrenia (see Table 1) [4]. For example, difficulties with emotional reciprocity, or speech delay observed in ASD may be understood in terms of blunting of affect or alogia (poverty of speech) in schizophrenia, respectively [5]. Catatonic features may also be present in both disorders. Conversely, positive symptoms, such as hallucinations and delusions, are defining features of schizophrenia but are not typically symptomatic of ASD [5]. Age of onset constitutes another significant distinction between the two constructs [6]. To date, little is known about mutual interactions between neurodevelopmental disorders, and the influence of psychosis on them. The research on neuropsychological processes has mainly revolved around executive function (EF) and theory of mind (ToM) [7,8], emphasizing the presence of common etiological mechanisms and shared genetic risk factors [9,10]. A recent metanalysis suggested an increased risk of psychotic disorder (PD), with a pooled relative effect of 4.74 (95% CI, 4.11–5.46) for patients with childhood ADHD. The association remained high for the more restrictive diagnosis of schizophrenia. The association between ADHD and subsequent psychosis could be explained considering many potential mechanisms, including shared genetic susceptibility or social environmental factors [11]. Furthermore, prenatal factors, such as diabetes during pregnancy or neonatal complications, are also frequently reported as risk factors for both disorders. It is also possible that the association between ADHD and PD is mediated by other factors. Attention-deficit/hyperactivity disorder has been described as a risk factor for substance use disorder (SUD), possibly because of increased impulsivity and a deficit in the dopaminergic reward system, and SUD, especially the use of cannabis, has been described as a risk factor for PD [12,13]. Krowkoski et al. suggested that a combined ASD–ADHD phenotype is characterized by two latent ASD domains (social communication and repetitive restrictive behavior) and two latent ADHD domains (inattention and hyperactivity/impulsivity), as demonstrated by an exploratory factor analysis and a confirmatory factor analysis [14]. Moreover, some evidence suggests three separate pathways explaining the comorbidity between ADHD and ASD. These pathways are from impulsivity to social information processing difficulties, from hyperactivity to restricted and repetitive behaviors and a pairwise pathway between inattention, verbal IQ and social information processing difficulties [15]. These data and others have led some to opine that it is not possible to determine if ADHD symptoms in ASD represent ASD, comorbid ADHD or a separate condition entirely. At this point, clinical impression remains the deciding factor which determines the most appropriate diagnosis for a patient (see Table 1) [8]. In this context, we discuss an emblematic case of a nine-year-old boy presenting with complex clinical features and overlapping conditions, requiring extensive and accurate evaluation.

2. Case Presentation

2.1. Social and Family History

The patient, Z, now a nine-year-old boy, was born to non-consanguineous parents. His father presented delusions of jealousy and persecution from the age of 20 years. Moreover, a maternal aunt suffered from epilepsy and other relatives in the maternal line were treated for unspecified anxiety and psychotic disorder. Finally, familiarity for intellectual disability in maternal and paternal lines was also reported.

2.2. Personal and Development History

The mother was primiparous and she denied consuming ethanol or illicit drugs during pregnancy. Z was born at term without complications and he did not demonstrate postnatal issues. Walking and talking milestones were in the normal range, however, a tendency to toe walking was reported. Moreover, parents reported from the first year of life, exaggerated responses to environmental stimuli (loud noises) and from the second year, of life repetitive behaviors such as turning on/off lights. At the age of 3 years, he presented with an acute episode of abnormal posture of the upper limbs maintained for about 10 h resembling dystonia. He was taken to the emergency room and later admitted to a hospital and a first diagnostic suspicion of chorea was made. Abnormal postures regressed spontaneously, however, after a few months, the clinical picture rapidly worsened; at this time, he was referred to our tertiary care center with concerns about marked irritability, obsessive thoughts, persistent impairment due to inattention. Moreover, auditory and visual hallucinations were reported.

2.3. Physical and Neurological Examination

The patient looked to be his stated age and had an average body build. He did not have dysmorphic facial features and neurological examination was unremarkable. At the time of our consultation, his interactions with the examiner were somewhat elusive; eye contact as well as communication skills were poor. He also exhibited repetitive patterns of behavior, interests and activities and he was impulsive and hyperactive. He presented rituals related to bathing and hand washing that were extremely disabling.

2.4. Laboratory Tests, Imaging and Genetic Assessment

Blood counts, renal and liver function tests, thyroid profile and other laboratory tests were unremarkable. In the suspicion of immune-mediated, infectious and/or metabolic disease, due to the aggravation of the clinical picture, the following examinations were also performed and resulted negative: metabolic work up, CSF analysis, serum autoantibodies. Moreover, an electroencephalogram (EEG) was performed and revealed nonspecific cerebral dysfunction and no epileptiform discharges. Finally, a brain magnetic resonance (MRI) showed no abnormalities. An array comparative genomic hybridization (aCGH) was performed on the patient’s parents and revealed normal genes. The FMR1 genetic test was likewise negative. He is now a candidate to whole-exome sequencing (WES).

2.5. Diagnosis

Even though an initial suspicion of chorea and early onset psychosis was posed, owing to the peculiar personal and developmental history, an in-depth diagnostic evaluation was performed. The Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Mania Rating Scale for Children and Adolescents [17] was administered to parents and confirmed a clinical score for Autism and ADHD. Due to deficits in social communication and repetitive patterns of interests, an ADOS-2 (Autism Diagnostic Observation Schedule) [18] was administered, reporting a total score of 13, which therefore exceeds the Autism cut-off in the ADOS-2 classification. An Autism diagnosis, according to DSM 5 criteria, ADOS2 and ADI-r scores [19], was made. The full assessment also included a cognitive evaluation and other specific tests exploring executive functions and psychiatric issues (i.e., the Nepsy II, Tower of London, CY-BOCS). Cognitive evaluation (Wechsler Intelligence Scale for Children-IV) [20] at 8 showed a full scale IQ score of 80, with a major discrepancy between the Verbal Comprehension Index (VCI = 106) and the Elaboration Speed Index (ESI = 53). Despite FIQ indicating low scores, cognitive functioning appears to be higher than measured and marred during the assessment by extreme hyperactivity and inattention. The Child Behavior Checklist [21] and the Conners’ Rating Scales-Revised [22] were administered to the parents and confirmed a clinical score for ADHD. Hence, he was found to meet the DSM-5 criteria for attention-deficit/hyperactivity disorder (ADHD) (combined-type). The Nepsy II [20] test revealed immature performance in understanding mental constructs, beliefs, deceptions and fictions (Theory of the Mind part A) as well as poor ability to set shift, highlighting an impulsive response style with poorly controlled output, poor cognitive flexibility, poor planning and adherence to rules. The Tower of London test [23] showed immature higher-order capabilities such as planning, strategic decision making and effective execution. Finally, mild obsessive-compulsive symptoms emerged from the Children’s Yale-Brown Obsessive Compulsive Scale (total score 11, Obsessions = 11, Compulsions = 0) [24]. The goal of this tool has been to assess the severity and quality of OC symptoms.

2.6. Management

Z initially received psychomotor and speech therapy, group therapy and at-home educational support. For the subsequent years, the patient was being followed up by occupational, behavioral and speech therapists. He has shown mild improvement in his attention span and communication skills. Despite dedicated work in behavioral and speech therapy, he is still showing dysfunctional behavior and he was not able to achieve a good development of adaptive and daily-living skills. Now he is attending primary school with a support teacher.
As most of ADHD plus ASD patients, Z required a combination of medication, psychosocial and behavioral interventions. For initial pharmacological management of emotional lability, carbamazepine was prescribed in another hospital, and then increased to 20 mL/die without significant clinical improvement on behavioral troubles. Subsequently, due to the high rate of irritability, risperidone was prescribed by our center, but rapidly discontinued due to the appearance of gynecomastia and hyperprolactinemia. Then, aripiprazole was titrated up to 10 mg/die with improvement in his behavior as well as him being calmer and more responsive. At this regard, the evidence confirms that the second-generation antipsychotics, particularly risperidone and aripiprazole, have been used for the short-term treatment of angry outbursts in children and adolescents with ASD, some of whom will have ADHD [25]. Low doses, regular reviews and short-term use are advised. However, there are variable degrees of official approval for their use between countries and behavioral and environmental interventions are first-line treatments [25]. The improvement of the symptomatology was confirmed by using the Clinical Global Impression Scale [26]. The patient’s score at admission to the project (CGI-S) was 6 (much worse). After the treatment, the patient’s score (CGI-I) was 5 (minimally worse).

3. Discussion

We reported a complex case of a nine-year-old boy who, crossing habitual diagnostic categories, presented with psychotic features and was finally diagnosed with ADHD and ASD. This case is emblematic of the myriad challenges of diagnosis in neuropsychiatric disorders and encourages careful evaluations in children presenting with multiple atypical symptoms. Actually, it is known that certain clinical features, such as psychomotor disturbances, social withdrawal and poor communication, stereotypies and perceptual disturbances, are characteristics of both psychotic disorders and ASD [27,28].
Moreover, the presence of auditory hallucinations in ASD has been reported [29].
Furthermore, a high rate of ADHD/ASD comorbidity is now established, and this dual diagnosis is often made, since DMS5 allows comorbid diagnosis [15].
Our patient presented psychotic features at onset, but his personal history analysis revealed features attributable to Autism Spectrum Disorder. What is more, the rapid evolution of the clinical picture was characterized by evidence of marked motor hyperkinesia and difficulty in concentration, compatible with ADHD. In this context, psychotic features resulted as the first manifestation and part of a complex clinical picture characterized by developmental disorders in a complex family environment.
Regarding the overlap diagnosis of ASD and ADHD, some authors suggest they are different manifestations of one overarching disorder, in which emotion regulation is a crucial common factor [30].
However, multiple executive functioning impairments are associated with both ADHD and ASD [31] and recent research has identified several neurocognitive features and underlying genetic substrate [32] that could help explain the co-occurrence of ADHD and Autism. However, neuropsychological assessment of executive functions does not fully account for the complexity of symptoms, so that clinical data and prolonged observation are essential for diagnosis.
This work highlights the importance of a complete diagnostic assessment in patients with unusual and complex semiological presentation [33], suggesting the possible overlap diagnosis of ADHD and Autism even in presence of psychotic-like symptoms.

4. Conclusions

The high prevalence of mental health and neurodevelopmental disorders comorbidities requires an accurate psychological assessment and use of standardized assessments and a diagnostic and statistical manual of mental disorders (DSM)-5-based assessment.
It can be useful to detect specific underlying processes differentiating the comorbid syndrome and plan an appropriate management and rehabilitation program.

Author Contributions

Conceptualization, V.S., M.M., M.N., S.G., M.R. and C.S.; methodology, V.S., M.M., M.N., S.G., M.R. and C.S.; software, V.S., M.M., M.N., S.G., M.R. and C.S.; validation, V.S., M.M., M.N., S.G., M.R. and C.S.; formal analysis, V.S., M.M., M.N., S.G., M.R. and C.S.; investigation, V.S., M.M., M.N., S.G., M.R. and C.S.; resources, V.S., M.M., M.N., S.G., M.R. and C.S.; data curation, V.S., M.M., M.N., S.G., M.R. and C.S.; writing—original draft preparation, V.S., M.M., M.N., S.G., M.R. and C.S.; writing—review and editing, V.S., M.M., M.N., S.G., M.R. and C.S.; visualization, V.S., M.M., M.N., S.G., M.R. and C.S.; supervision, C.S. and M.R.; project administration, C.S. and M.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Sapienza University of Rome, Umberto I Hospital, Approval Code: 4816, Approval Date: 1 February 2018.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Antshel, K.M.; Russo, N. Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations. Curr. Psychiatry Rep. 2019, 21, 34. [Google Scholar] [CrossRef] [PubMed]
  2. Lecavalier, L.; McCracken, C.E.; Aman, M.G.; McDougle, C.J.; McCracken, J.T.; Tierney, E.; Smith, T.; Johnson, C.; King, B.; Handen, B.; et al. An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. Compr. Psychiatry 2018, 88, 57–64. [Google Scholar] [CrossRef] [PubMed]
  3. Leitner, Y. The co-occurrence of autism and attention deficit hyperactivity disorder in children—What do we know? Front. Hum. Neurosci. 2014, 8, 268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Trevisan, D.A.; Foss-Feig, J.H.; Naples, A.J.; Srihari, V.; Anticevic, A.; McPartland, J.C. Autism Spectrum Disorder and Schizophrenia Are Better Differentiated by Positive Symptoms Than Negative Symptoms. Front. Psychiatry 2020, 11, 548. [Google Scholar] [CrossRef] [PubMed]
  5. Kincaid, D.L.; Doris, M.; Shannon, C.; Mulholland, C. What is the prevalence of autism spectrum disorder and ASD traits in psychosis? A systematic review. Psychiatry Res. 2017, 250, 99–105. [Google Scholar] [CrossRef] [Green Version]
  6. Konstantareas, M.M.; Hewitt, T. Autistic Disorder and Schizophrenia: Diagnostic Overlaps. J. Autism Dev. Disord. 2001, 31, 19–28. [Google Scholar] [CrossRef]
  7. Vaskinn, A.; Abu-Akel, A. The interactive effect of autism and psychosis severity on theory of mind and functioning in schizophrenia. Neuropsychology 2019, 33, 195–202. [Google Scholar] [CrossRef] [Green Version]
  8. Antshel, K.M.; Zhang-James, Y.; Wagner, K.E.; Ledesma, A.; Faraone, S.V. An update on the comorbidity of ADHD and ASD: A focus on clinical management management. Expert Rev. Neurother. 2016, 16, 279–293. [Google Scholar] [CrossRef]
  9. Rommelse, N.N.J.; Geurts, H.M.; Franke, B.; Buitelaar, J.K.; Hartman, C.A. A review on cognitive and brain endophenotypes that may be common in autism spectrum disorder and attention-deficit/hyperactivity disorder and facilitate the search for pleiotropic genes. Neurosci. Biobehav. Rev. 2011, 35, 1363–1396. [Google Scholar] [CrossRef]
  10. Sandin, S.; Lichtenstein, P.; Kuja-Halkola, R.; Larsson, H.; Hultman, C.M.; Reichenberg, A. The familial risk of autism. JAMA J. Am. Med. Assoc. 2014, 311, 1770–1777. [Google Scholar] [CrossRef]
  11. Nourredine, M.; Gering, A.; Fourneret, P.; Rolland, B.; Falissard, B.; Cucherat, M.; Geoffray, M.-M.; Jurek, L. Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence with the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-Analysis. JAMA Psychiatry 2021, 78, 519–529. [Google Scholar] [CrossRef] [PubMed]
  12. Özgen, H.; Spijkerman, R.; Noack, M.; Holtmann, M.; Schellekens, A.S.A.; van de Glind, G.; Banaschewski, T.; Barta, C.; Begeman, A.; Casas, M.; et al. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. Eur. Addict. Res. 2020, 26, 54–67. [Google Scholar] [CrossRef] [PubMed]
  13. Chisholm, K.; Lin, A.; Abu-Akel, A.; Wood, S.J. The association between autism and schizophrenia spectrum disorders: A review of eight alternate models of co-occurrence. Neurosci. Biobehav. Rev. 2015, 55, 173–183. [Google Scholar] [CrossRef] [Green Version]
  14. Krakowski, A.D.; Cost, K.T.; Szatmari, P.; Anagnostou, E.; Crosbie, J.; Schachar, R.; Duku, E.; Georgiades, S.; Ayub, M.; Kelley, E.; et al. Characterizing the ASD–ADHD phenotype: Measurement structure and invariance in a clinical sample. J. Child Psychol. Psychiatry 2022, preprint. [Google Scholar] [CrossRef]
  15. Sokolova, E.; Oerlemans, A.M.; Rommelse, N.N.; Groot, P.; Hartman, C.A.; Glennon, J.C.; Claassen, T.; Heskes, T.; Buitelaar, J.K. A causal and mediation analysis of the comorbidity between attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). J. Autism Dev. Disord. 2017, 47, 1595–1604. [Google Scholar] [CrossRef] [Green Version]
  16. Regier, D.A.; Kuhl, E.A.; Kupfer, D.J. The DSM-5: Classification and criteria changes. World Psychiatry 2013, 12, 92–98. [Google Scholar] [CrossRef] [Green Version]
  17. Axelson, D.; Birmaher, B.J.; Brent, D.; Wassick, S.; Hoover, C.; Bridge, J.; Ryan, N. A Preliminary Study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Mania Rating Scale for Children and Adolescents. J. Child Adolesc. Psychopharmacol. 2003, 13, 463–470. [Google Scholar] [CrossRef] [PubMed]
  18. Holzinger, D.; Weber, C.; Bölte, S.; Fellinger, J.; Hofer, J. Assessment of Autism Spectrum Disorder in Deaf Adults with Intellectual Disability: Feasibility and Psychometric Properties of an Adapted Version of the Autism Diagnostic Observation Schedule (ADOS-2). J. Autism Dev. Disord. 2022, 52, 3214–3227. [Google Scholar] [CrossRef]
  19. Kim, S.H.; Bal, V.H.; Lord, C. Autism Diagnostic Interview-Revised. In Encyclopedia of Autism Spectrum Disorders; Springer: Cham, Switzerland, 2021. [Google Scholar]
  20. Needelman, H.; Schnoes, C.J.; Ellis, C.R. The new WISC-IV. J. Dev. Behav. Pediatrics 2006, 27, 127–128. [Google Scholar] [CrossRef]
  21. Achenbach, T.M. Child Behavior Checklist. In Encyclopedia of Clinical Neuropsychology, 2011 ed.; Kreutzer, J.S., DeLuca, J., Caplan, B., Eds.; Springer: New York, NY, USA, 2011. [Google Scholar]
  22. Deb, S.; Dhaliwal, A.J.; Roy, M. The usefulness of Conners’ Rating Scales-Revised in screening for Attention Deficit Hyperactivity Disorder in children with intellectual disabilities and borderline intelligence. J. Intellect. Disabil. Res. 2008, 52, 950–965. [Google Scholar] [CrossRef]
  23. Shallice, T. Specific impairments of planning. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1982, 298, 199–209. [Google Scholar] [PubMed]
  24. Storch, E.A.; Murphy, T.K.; Geffken, G.R.; Soto, O.; Sajid, M.; Allen, P.; Roberti, J.W.; Killiany, E.M.; Goodman, W.K. Psychometric evaluation of the Children’s Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res. 2004, 129, 91–98. [Google Scholar] [CrossRef] [PubMed]
  25. Young, S.; Hollingdale, J.; Absoud, M.; Bolton, P.; Branney, P.; Colley, W.; Craze, E.; Dave, M.; Deeley, Q.; Farrag, E.; et al. Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus. BMC Med. 2020, 18, 146. [Google Scholar] [CrossRef] [PubMed]
  26. Busner, J.; Targum, S.D. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry 2007, 4, 28–37. [Google Scholar] [PubMed]
  27. Petty, L.K.; Ornitz, E.M.; Michelman, J.D.; Zimmerman, E.G. Autistic children who become schizophrenic. Arch. Gen. Psychiatry 1984, 41, 129–135. [Google Scholar] [CrossRef]
  28. King, B.H.; Lord, C. Is schizophrenia on the autism spectrum? Brain Res. 2011, 1380, 34–41. [Google Scholar] [CrossRef]
  29. Kiyono, T.; Morita, M.; Morishima, R.; Fujikawa, S.; Yamasaki, S.; Nishida, A.; Ando, S.; Kasai, K. The Prevalence of Psychotic Experiences in Autism Spectrum Disorder and Autistic Traits: A Systematic Review and Meta-analysis. Schizophr. Bull. Open 2020, 1, sgaa046. [Google Scholar] [CrossRef]
  30. Collin, L.; Bindra, J.; Raju, M.; Gillberg, C.; Minnis, H. Facial emotion recognition in child psychiatry: A systematic review. Res. Dev. Disabil. 2013, 34, 1505–1520. [Google Scholar] [CrossRef]
  31. Carter Leno, V.; Chandler, S.; White, P.; Pickles, A.; Baird, G.; Hobson, C.; Smith, A.B.; Charman, T.; Rubia, K.; Simonoff, E. Testing the specificity of executive functioning impairments in adolescents with ADHD, ODD/CD and ASD. Eur. Child Adolesc. Psychiatry 2018, 27, 899–908. [Google Scholar] [CrossRef] [Green Version]
  32. Ghirardi, L.; Brikell, I.; Kuja-Halkola, R.; Freitag, C.M.; Franke, B.; Asherson, P.; Lichtenstein, P.; Larsson, H. The familial co-aggregation of ASD and ADHD: A register-based cohort study. Mol. Psychiatry 2018, 23, 257–262. [Google Scholar] [CrossRef]
  33. Fioriello, F.; Maugeri, A.; D’Alvia, L.; Pittella, E.; Piuzzi, E.; Rizzuto, E.; Del Prete, Z.; Manti, F.; Sogos, C. A wearable heart rate measurement device for children with autism spectrum disorder. Sci. Rep. 2020, 10, 18659. [Google Scholar] [CrossRef] [PubMed]
Table 1. Overlap symptoms and differences between ADHD, ASD and psychosis.
Table 1. Overlap symptoms and differences between ADHD, ASD and psychosis.
Overlap SymptomsDifferences
Inattention (ASD + ADHD)
[15]
Restricted interests (ASD)
[16]
Problems in social interaction with peers
(ASD + ADHD) [14]
Restricted repetitive behavior (ASD) [16]
Atypical neuro-development of language (ASD + Psychosis)
[5]
Impulsivity (ADHD)
[16]
Difficulties with social interaction and communication (ASD + Psychosis)
[7]
Evidence of prominent hallucinations for at least one month (Psychosis)
[16]
Impairment in social functioning (ASD + Psychosis)
[7]
Evidence of prominent delusions for at least one month (Psychosis)
[16]
Difficulties with emotional reciprocity (ASD + Psychosis)
[6]
Struggle with inhibition (ADHD)
[1]
Speech delay or absence/alogia
(ASD + Psychosis)
[6]
Struggle with planning (ADHD)
[1]
Catatonic features
(ASD + Psychosis)
[6]
Struggle with cognitive flexibility (ASD)
[1]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Scarselli, V.; Martucci, M.; Novelli, M.; Galosi, S.; Romani, M.; Sogos, C. Diagnostic and Therapeutic Challenges of Comorbid ASD, ADHD and Psychosis: A Case Report. Behav. Sci. 2022, 12, 382. https://doi.org/10.3390/bs12100382

AMA Style

Scarselli V, Martucci M, Novelli M, Galosi S, Romani M, Sogos C. Diagnostic and Therapeutic Challenges of Comorbid ASD, ADHD and Psychosis: A Case Report. Behavioral Sciences. 2022; 12(10):382. https://doi.org/10.3390/bs12100382

Chicago/Turabian Style

Scarselli, Veronica, Melania Martucci, Maria Novelli, Serena Galosi, Maria Romani, and Carla Sogos. 2022. "Diagnostic and Therapeutic Challenges of Comorbid ASD, ADHD and Psychosis: A Case Report" Behavioral Sciences 12, no. 10: 382. https://doi.org/10.3390/bs12100382

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop